| | Compliance Through Science: US Pharmaceutical Industry |
| | 1,45 | | MB | Experts on a Strengthened Bioweapons Nonproliferation |
| | 82 | | stron |
| | 1074 | | ID | Henry L. Stimson Center |
| | 2002 | | rok |
| | Table of Contents |
| | Preface and Acknowledgements.i |
| | Table of Contents .v |
| | List of Abbreviations .vii |
| | Executive Summary ix |
| | Chapter 1: Introduction.1 |
| | The International Regime Against Biological Weapons ..2 |
| | The US Alternative Proposals .11 |
| | Methodology of the Report ..12 |
| | Chapter 2: Evaluating US Proposals to Monitor Compliance with the BWC15 |
| | A Deal Best Refused 15 |
| | An Industry Approach to BWC Monitoring.17 |
| | Evaluating the US Government's Alternative BWC Monitoring Proposals 23 |
| | Charting a Course Forward ..25 |
| | Chapter 3: Considering the US Proposals to Criminalize Offensive Biological Weapons |
| | Activities, Enhance Global Disease Surveillance, and Institute Scientific Codes of Ethics27 |
| | Criminalization of Offensive Biological Weapons Activities.27 |
| | Improving Global Disease Surveillance.31 |
| | Instituting Ethics Codes for Scientists.36 |
| | Chapter 4: Considering US Proposals for Enhanced Biosafety, Biosecurity, and |
| | Research Oversight .43 |
| | Putting Backbone in the United States Biosafety Initiative .46 |
| | Strengthening the US Biosecurity Initiative.50 |
| | Creating More Rigorous Oversight of Genetic Engineering Research ..54 |
| | Concluding Thoughts on Implementation.55 |
| | Chapter 5: Concluding Observations and Recommendations .59 |
| | Alternative Proposals: Individual State Activities 60 |
| | Alternative Proposals: Traditional Inspection Activities ..65 |
| | Concluding Observations ..67 |
| | Appendix: Participant Biographies ..69 |